By Karen Lightman, managing director, MEMS Industry Group
For those of you who have heard me talk about MEMS and Medical/Quality of Life (QoL applications – I don’t shy away from calling it “God’s work.” I still get misty-eyed when I think about my friend’s ten year-old daughter, Anna, who has type 1 Diabetes. Last year I told Anna about technology from MicroCHIPS that (thanks to the wonders of MEMS) will someday enable her to seamlessly and automatically monitor and dose her insulin without having to prick her finger and then calculate and administer a dose before every meal or snack. She’ll get her dignity back and she’ll improve her quality of life.
The Holy Grail in medicine is not diagnosing Diabetes, Alzheimer’s or even obesity; it’s figuring out what’s next and how to deal with it. MEMS technology can and will help to navigate that path.
With MEMS technology fundamental to new medical/QoL devices and applications, understanding opportunities in this rapid-growth market is more important than ever. At MEMS Executive Congress US 2012, we’ve lined up a panel of industry experts to discuss how MEMS continues to play a critical role in the development of new technologies that assist with patient monitoring, diagnostics, therapy and portable health care.
To preview our panel, I’ve invited my moderator, Jeannette F. Wilson, product line manager, Sensor and Actuator Solution Division (SASD) / AISG, Freescale Semiconductor, to introduce our panelists and share her thoughts on what they will discuss.